Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rocket Pharmaceuticals Inc shares valued at $114,581 were sold by Militello John on Oct 14 ’25. At $3.96 per share, Militello John sold 28,918 shares. The insider’s holdings dropped to 67,006 shares worth approximately $0.22 million following the completion of this transaction.
Also, Militello John purchased 28,918 shares, netting a total of over 114,581 in proceeds.
Before that, Bjork Elisabeth had added 10,000 shares to its account. In a trade valued at $34,100, the Director bought Rocket Pharmaceuticals Inc shares for $3.41 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.13 million.
As published in a research note from BofA Securities on August 20, 2025, Rocket Pharmaceuticals Inc [RCKT] has been rated up from a Neutral to a Buy and the price target has been revised to $10. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late July. As of May 30, 2025, Evercore ISI has decreased its “an Outperform” rating to a “an In-line” for RCKT. Earlier on May 28, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for RCKT stock which previously was a “an Overweight”.
Analyzing RCKT Stock Performance
On last trading session, Rocket Pharmaceuticals Inc [NASDAQ: RCKT] plunged -2.71% to $3.23. The stock’s lowest price that day was $3.16, but it reached a high of $3.35 in the same session. During the last five days, there has been a drop of approximately -12.70%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -80.80%. Shares of the company reached a 52-week high of $13.35 on 01/02/25 and a 52-week low of $2.19 on 05/27/25.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 3.14, which, if violated, would cause prices to drop to 3.06. In the upper region, resistance lies at 3.33. The next price resistance is at 3.44. RSI (Relative Strength Index) is 40.21 on the 14-day chart, showing neutral technical sentiment.
Is Rocket Pharmaceuticals Inc subject to short interest?
Stocks of Rocket Pharmaceuticals Inc saw a sharp steep in short interest on 2025-10-15 dropping by -2.49 million shares to 12.4 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 14.89 million shares. A decline of -20.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.94 of the overall float, the days-to-cover ratio (short ratio) decline to 3.94.
Which companies own the most shares of Rocket Pharmaceuticals Inc (RCKT)?
In terms of Rocket Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 2.5 in the next 12 months, down nearly -24.7% from the previous closing price of $3.32. Analysts anticipate Rocket Pharmaceuticals Inc stock to reach 7 by 2025, with the lowest price target being 2. In spite of this, 8 analysts ranked Rocket Pharmaceuticals Inc stock as Buy at the end of 2025. On May 28, 2025, Leerink Partners assigned a price target of “a Market perform” to the stock and downgraded coverage with a $8.
